Israel issues compulsory license to allow the government to import generic versions of Kaletra

(More on COVID-19 here: https://www.keionline.org/coronavirus) On Wednesday, 18 March 2020 (22nd of Adar, 5780), Israel’s Minister of Health, MP Rabbi Yaacov Litzman, issued a Permit to the State to Exploit an Invention Pursuant to Chapter Six, Article Three of the… Continue Reading

Legislative Committee in Ecuador approves resolution on compulsory licensing of patents relating to the coronavirus

For more on KEI’s work on COVID-19, see keonline.org/coronavirus. Today, the Education, Culture, Science and Technology Commission of the National Assembly in Ecuador approved a resolution asking the Minister of Health to issue compulsory licenses over patents related to coronavirus… Continue Reading

KEI Blogs and Reseach notes on COVID-19/Coronavirus

COVID-19 Gov’t Contracts: KEI has obtained numerous contracts between the federal government and pharmaceutical companies regarding COVID-19 medical technologies via the Freedom of Information act. For these and other contracts, please see: https://www.keionline.org/covid-contracts. COVID-19 Vaccine Manufacturing: KEI has gathered data… Continue Reading

English translation of Chile “RESOLUTION FOR THE GRANTING OF NON-VOLUNTARY LICENSES REFERRED TO IN ARTICLE 51º Nº 2 OF INDUSTRIAL PROPERTY LAW Nº 19.030 TO FACILITATE ACCESS AND AVAILABILITY OF MEDICINES AND TECHNOLOGIES FOR THE PREVENTION, TREATMENT AND CURE OF CORONAVIRUS COVID-19”

The following is an English translation resolution 896, that was adopted by the Chile Chamber of Deputies on March 17, 2020, by a vote of 127 to 0. The original resolution, in Spanish, is available here. KEI has a blog… Continue Reading

Three areas in Section 202 of the Bayh-Dole Act that require action to ensure sufficient rights in patents on coronavirus relevant inventions

For more on KEI’s work on COVID-19, see keonline.org/coronavirus. As the US and other governments begin to expend large amounts of money on research and development related to the control, prevention and treatment of the coronavirus pandemic, there are important… Continue Reading

WIPO’s Coordination Committee nominates Daren Tang of Singapore for the Post of Director General

Updated between 11 March 2020 to 18 March 2020 to include reactions from stakeholders on the nomination of Daren Tang (Singapore) as Director General of the World Intellectual Property Organization (WIPO) Brook K. Baker, Senior Policy Analyst Health GAP (Global… Continue Reading

Unreasonable pricing and the “Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020”

For more on KEI’s work on COVID-19, see keonline.org/coronavirus. The “Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020’’ will provide welcome funding to deal with the expanding COVID-19 pandemic. The current language on affordability (this Draft text), however, is worse… Continue Reading

WTO TRIPS Council discussions on the transparency of R&D costs and the pricing of medicines: The Good, The Bad, and The Ugly

In February 2020, the World Trade Organization (WTO) de-restricted the minutes of the TRIPS Council’s October 2019 session. While the official minutes (IP/C/M/93/Add.1) were circulated to WTO members on 9 December 2019, the October 2019 minutes were only available to… Continue Reading